Reference:WMA Declaration of Helsinki 2024 Paragraph 36: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
imported>GxPlexBot Import from GxPlex Excel |
||
| Line 4: | Line 4: | ||
|RefDocPart=Paragraph 36 | |RefDocPart=Paragraph 36 | ||
|RefLanguage=EN | |RefLanguage=EN | ||
| | |RefTags=TAG-00075-Pub-ich ++ TAG-00051-Eth-ngs ++ TAG-00341-Res-ben ++ TAG-00017-Spo-die | ||
| | |RefModule=6 | ||
| | |RefUnit=6.5.0 | ||
}} | }} | ||
| Line 14: | Line 14: | ||
|- | |- | ||
! colspan="2" class="gplx-infobox-header" | Reference Details | ! colspan="2" class="gplx-infobox-header" | Reference Details | ||
|- | |||
! Module | |||
| Module 6 β Unit 6.5.0 | |||
|- | |- | ||
! Scope | ! Scope | ||
| Line 30: | Line 33: | ||
| Β | | Β | ||
|- | |- | ||
! Tags | ! Tags | ||
| Β | | [[Glossary:TAG-00075-Pub-ich|Publication]], [[Glossary:TAG-00051-Eth-ngs|Ethics]], [[Glossary:TAG-00341-Res-ben|Responsibilities]], [[Glossary:TAG-00017-Spo-die|Sponsor]] | ||
|- | |||
| Β | |||
|- | |||
| Β | |||
|- | |- | ||
! Comment | ! Comment | ||
Revision as of 17:29, 15 July 2026
| Document information | |
|---|---|
| Reference | WMA Declaration of Helsinki 2024 |
| Validity area | WMA |
| Scope(s) | G |
| Document name | Declaration of Helsinki |
| Version / Revision | 2024 |
| Status | Current |
| Document type | International guideline |
| Language(s) | EN |
| Description | Declaration of Helsinki
Medical Research Involving Human Participants The Declaration of Helsinki (DoH) is the World Medical Associationβs (WMA) best-known policy statement. The first version was adopted in 1964 and has been amended seven times since, most recently at the General Assembly in October 2024. The current (2024) version is the only official one; all previous versions* have been replaced and should not be used or cited except for historical purposes. The WMA would like to thank all those who submitted comments and suggestions for the most recent revision of the DoH. |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 6 β Unit 6.5.0 |
| Scope | G |
| Document part | Paragraph 36 |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Publication, Ethics, Responsibilities, Sponsor |
| Comment | Ethical obligations for publication and handling of negative results |
Content
36. Researchers, authors, sponsors, editors, and publishers all have ethical obligations with regard to the publication and dissemination of the results of research. Researchers have a duty to make publicly available the results of their research on human participants and are accountable for the timeliness, completeness, and accuracy of their reports. All parties should adhere to accepted guidelines for ethical reporting. Negative and inconclusive as well as positive results must be published or otherwise made publicly available. Sources of funding, institutional affiliations, and conflicts of interest must be declared in the publication. Reports of research not in accordance with the principles of this Declaration should not be accepted for publication.
